William Catterall

William Catterall
pas labex
pas Eurias

dates de séjour

18/09/2010 - 18/10/2010

discipline

Sciences de la santé

Fonction d’origine

Professeur

Institution d’origine

Département de Pharmacologie, Université de Washington, Seattle (États-Unis)

pays d'origine

États-Unis

projet de recherche

Electrical Signaling, Ion Channelopathies, and Bioethics of Inherited Brain Diseases

Nerve cells in the brain communicate with each other by electrical signals that are transmitted from cell to cell at specialized junctions called synapses. Electrical signaling and synaptic transmission are disrupted in neurological and psychiatric diseases. This proposed IMeRA project would address this area of research through luncheon discussions focusing on electrical signaling and synaptic plasticity in the normal brain, impairment of these processes in brain diseases; participation in an IMeRA seminar on humanistic aspects of brain science; a workshop on: Electrical Signaling, Ion Channelopathies, and Bioethics of Inherited Diseases in the Brain, and participation in a collaborative laboratory research project with Dr. Michael Seagar, Director of INSERM Unit 641 at Université de la Mediterranée on “Protein Interactions in the Molecular Network Regulating Calcium Channels and Synaptic Plasticity in the Brain”.

biographie

William Catterall is a biologist and a professor at the Department of Pharmacology (University of Washington, Seattle). He holds a B.A. in Chemistry from Brown University in 1968, a Ph.D. in Physiological Chemistry from Johns Hopkins in 1972, and postdoctoral training in neurobiology and molecular pharmacology as a Muscular Dystrophy Association Fellow at the National Institutes of Health from 1972 to 1974. He joined the University of Washington in 1977 as Associate Professor of Pharmacology, became Professor in 1981, and served as Chair from 1984-2016. William Catterall has received numerous awards, including the Gairdner International Award of Canada in 2010 and the Robert Ruffolo Career Achievement Award from the American Society of Pharmacology & Experimental Therapeutics in 2016.